Gene-Activators Prevent and Regress Atherosclerosis and Reduce Mortality

Publisher： Bentham Science Publishers

E-ISSN： 1875-6182|7|4|295-304

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.7, Iss.4, 2009-10, pp. : 295-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular biology and gene transfer in atherosclerosis in the stenting era

By Caplice Noel M   Simari Robert D   Holmes David R  

International Journal of Cardiovascular Interventions, Vol. 2, Iss. 3, 1999-01 ,pp. : 141-152

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory Cytokines and Atherosclerosis Possible Application for the Gene Therapy

By  

Vascular Disease Prevention, Vol. 2, Iss. 2, 2005-04 ,pp. : 115-120

Bentham Science Publishers

Access to resources Recommend Favorite

Arterial Stiffness:A Potential Therapeutic Target to Reduce Cardiovascular Mortality

By  

Current Hypertension Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 97-102

Bentham Science Publishers

Access to resources Recommend Favorite

Postprandial Glucose - A Potential Therapeutic Target to Reduce Cardiovascular Mortality

By  

Current Vascular Pharmacology, Vol. 7, Iss. 1, 2009-01 ,pp. : 68-74

Bentham Science Publishers

Access to resources Recommend Favorite

5‐Lipoxygenase Gene Variants Are Not Associated With Atherosclerosis or Incident Coronary Heart Disease in the Multi‐Ethnic Study of Atherosclerosis Cohort

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 3, 2016-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite